Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD MS, Can-Lan Sun, PhD, Kirsten K. Ness, PhD, Jennifer Berano Teh, MD, Jessica Wu, Liton F. Francisco, BS, Saro Armenian, DO, MPH, Amy Schad, MPH, CCRP, Golnaz Namdar, MPH, Alysia Bosworth, Linus Kuo, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, MD MPH

Blood (2015) 126 (23): 739.

https://doi.org/10.1182/blood.V126.23.739.739

Published: 2015

Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS

Blood (2014) 124 (21): 4383.

https://doi.org/10.1182/blood.V124.21.4383.4383

Published: 2014

Journal Articles

What Predicts Success for a New Composite Endpoint: Graft–versus-Host Disease-Free and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation?

Shernan G. Holtan, MD, Todd E. DeFor, MS, Aleksandr Lazaryan, MD PhD MPH, Nelli Bejanyan, MD, Mukta Arora, MD MS, Bruce R. Blazar, MD, Margaret L. MacMillan, MD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 429.

https://doi.org/10.1182/blood.V124.21.429.429

Published: 2014

Journal Articles

Clinical Relevance of HLA Supertype Matching after Myeloablative Conditioning 7/8 Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Study

Aleksandr Lazaryan, MD PhD MPH, Tao Wang, PhD, Stephen R. Spellman, MBS, Hai-Lin Wang, MPH, Carlheinz R. Müller, MD PhD, Marcelo A. Fernandez-Viña, PhD D(ABHI), Michael R. Verneris, MD, Mukta Arora, MD MS, Daniel J. Weisdorf, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD MPH

Blood (2014) 124 (21): 2572.

https://doi.org/10.1182/blood.V124.21.2572.2572

Published: 2014

Journal Articles

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

Aleksandr Lazaryan, MD PhD MPH, Todd E. DeFor, MS, Claudio Brunstein, MD, Margaret L. MacMillan, MD, Nelli Bejanyan, MD, Shernan G. Holtan, MD, Bruce R. Blazar, MD, John E Wagner, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD MS

Blood (2014) 124 (21): 189.

https://doi.org/10.1182/blood.V124.21.189.189

Published: 2014

Journal Articles

A Refined Clinical Risk Score at Onset of Treatment for Acute Gvhd That Predicts Response to Initial Therapy, Survival and Transplant-Related Mortality

Margaret L. MacMillan, MD, Marie Robin, MD PhD, Andrew C Harris, MD, Todd E. Defor, MS, Paul J. Martin, MD, Amin Alousi, MD, Vincent T Ho, MD, Javier Bolanos-Meade, MD, James L.M. Ferrara, MD, D.Sc., Richard J. Jones, MD, Mukta Arora, MD MS, Bruce R. Blazar, MD, Shernan G. Holtan, MD, David Jacobsohn, MD, Marcelo C. Pasquini, MD MS, Gerard Socie, MD PhD, Joseph H. Antin, MD, John E. Levine, MD, M.S., Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 188.

https://doi.org/10.1182/blood.V124.21.188.188

Published: 2014

Journal Articles

Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients

Hewan Belete, MDcal student, Linda J. Burns, MD, Ryan Shanley, MS, Manju Nayar, MBBS, Brian McClune, DO, Nishant Sahni, MDMS, Aleksandr Lazaryan, MD PhD, Veronika Bachanova, MD, Daniel J. Weisdorf, MD, Mukta Arora, MD MS

Blood (2014) 124 (21): 3965.

https://doi.org/10.1182/blood.V124.21.3965.3965

Published: 2014

Journal Articles

Day 21 Chimerism Is a Critical Prognostic Factor for Graft Failure and Survival in Recipients of Myeloablative Conditioning and Umbilical Cord Blood (UCB) Transplantation

Nelli Bejanyan, MD, Claudio G Brunstein, MD, Qing Cao, MS, Bharat Thyagarajan, MD PhD, Karamjeet S. Sandhu, MD, Mukta Arora, MD MS, Daniel J. Weisdorf, MD, John E Wagner, MD

Blood (2014) 124 (21): 3867.

https://doi.org/10.1182/blood.V124.21.3867.3867

Published: 2014

Journal Articles

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

Alvaro Urbano-Ispizua, MD, Steven Z. Pavletic, MD, Mary E. D. Flowers, MD, Mei-Jie Zhang, PhD, Jeanette Carreras, MPH, Sonali M. Smith, MD, David G. Maloney, MD, PhD, Silvia Montoto, MD, Corey S. Cutler, MD, MPH, FRCPC, Stephen R Spellman, MBS, Mukta Arora, MD, MS, Wael Saber, MD, MS

Blood (2013) 122 (21): 2093.

https://doi.org/10.1182/blood.V122.21.2093.2093

Published: 2013

Journal Articles

Influence Of Organ Scores On Mortality In Chronic GVHD: Results From The Chronic GVHD Consortium

Yoshihiro Inamoto, MD, PhD, Barry E. Storer, PhD, Daniel J. Weisdorf, MD, Georgia B. Vogelsang, MD, Joseph Pidala, MD, MS, Xiaoyu Chai, MS, Mary E. D. Flowers, MD, Mukta Arora, MD, MS, Sally Arai, MD, Jeanne Palmer, MD, Corey S. Cutler, MD, Madan Jagasia, MBBS, MS, Steven Z. Pavletic, MD, Stephanie J. Lee, MD, MPH, Paul J. Martin, MD

Blood (2013) 122 (21): 4614.

https://doi.org/10.1182/blood.V122.21.4614.4614

Published: 2013

Journal Articles

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

Sally Arai, MD, Mukta Arora, MD, MS, Tao Wang, PhD, Wensheng He, PhD, MS, Daniel R. Couriel, MD, Alvaro Urbano-Ispizua, MD, Corey S. Cutler, MD, Stephen Spellman, MBS, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 3309.

https://doi.org/10.1182/blood.V122.21.3309.3309

Published: 2013

Journal Articles

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

Saro Armenian, D.O., M.P.H., Can-Lan Sun, PhD, Mukta Arora, MD, MS, K. Scott Baker, MD, MS, Liton Francisco, Joseph Rosenthal, MD, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia, Ph.D.

Blood (2013) 122 (21): 553.

https://doi.org/10.1182/blood.V122.21.553.553

Published: 2013

Journal Articles

Do Older Patients With Moderate-Severe Chronic Graft-Versus-Host Disease Differ From Younger Patients?

Areej El-Jawahri, MD, Joseph Pidala, MD, MS, Xiaoyu Chai, MS, William A. Wood, MD, MPH, Nandita Khera, MD, MPH, Mukta Arora, MD, MS, Samantha M. Jaglowski, MD, MPH, Stephanie J. Lee, MD, MPH, Yi-Bin Chen, MD

Blood (2013) 122 (21): 725.

https://doi.org/10.1182/blood.V122.21.725.725

Published: 2013

Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Blood (2013) 122 (21): 706.

https://doi.org/10.1182/blood.V122.21.706.706

Published: 2013

Journal Articles

Correlation of the NIH and Vienna Skin Scores with Provider and Patient-Reported Skin Changes in Chronic Graft-Versus-Host Disease (GVHD).

David Jacobsohn, MD, ScM, Xiaoyu Chai, MS, Brenda Kurland, PhD, Sally Arai, MD, Mukta Arora, MD, MS, Corey Cutler, MD, MPH, Madan Jagasia, MD, MS, Steven Z. Pavletic, MD, Georgia Vogelsang, Stephanie J. Lee, MD, MPH, Mary E.D. Flowers, MD

Blood (2009) 114 (22): 2256.

https://doi.org/10.1182/blood.V114.22.2256.2256

Published: 2009

Journal Articles

Hospitalization Rates Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report From the Childhood Cancer Survivor Study (CCSS).

Vikki G Nolan, DSc, MPH, Beth Kurt, MD, MS, Kirsten K Ness, PhD, Joseph P. Neglia, Jean Tersak, MD, Melissa M. Hudson, MD, Gregory Armstrong, MD, Wendy Leisenring, Sc.D., Leslie L. Robison, PhD, MPH, Mukta Arora, MD, MS

Blood (2009) 114 (22): 4633.

https://doi.org/10.1182/blood.V114.22.4633.4633

Published: 2009

Journal Articles

Association Between Genetic Variants in the Base Excision Repair Pathway and Outcomes After Hematopoietic Cell Transplant.

Mukta Arora, MD, MS, Bruce Lindgren, MS, Saonli Basu, PhD, Sriharsha Nagaraj, MBBS, MS, Myron Gross, PhD, Daniel J Weisdorf, MD, Bharat Thyagarajan, MD, PhD

Blood (2009) 114 (22): 870.

https://doi.org/10.1182/blood.V114.22.870.870

Published: 2009

Journal Articles

High Resolution HLA Matched Unrelated Donor Versus HLA Identical Sibling Transplantation for Chronic Phase CML.

Mukta Arora, MD, MS, Stephen Spellman, MBS, Michael Haagenson, MS, John P. Klein, PhD, Carolyn Hurley, PhD, George Selby, MD, Joseph Antin, MD, Nancy Kernan, MD, Craig Kollman, PhD, Auayporn Nademanee, MD, Daniel J. Weisdorf, MD, Mary M. Horowitz, MD, MS, Philip McGlave, MD, Effie Petersdorf, MD

Blood (2007) 110 (11): 171.

https://doi.org/10.1182/blood.V110.11.171.171

Published: 2007

Journal Articles

New Classification of Chronic Graft Versus Host Disease: Added Clarity from the Consensus Diagnoses.

Mukta Arora, MD, MS, Sriharsha Nagaraj, MBBS, Judy Witte, Todd E. DeFor, MS, Margaret L. MacMillan, MD, Linda J. Burns, MD, Daniel J. Weisdorf, MD

Blood (2007) 110 (11): 41.

https://doi.org/10.1182/blood.V110.11.41.41

Published: 2007

Journal Articles

Graft-Versus-Leukemia Effect Is Equivalent in Recipients of Matched Sibling and Matched Unrelated Donor Conventional Hematopoietic Cell Transplant.

Blood (2007) 110 (11): 3049.

https://doi.org/10.1182/blood.V110.11.3049.3049

Published: 2007

NARROW

Physiologic Frailty Among Hematopoietic Cell Transplantation (HCT) Survivors Suggests Accelerated Aging and Is a Predictor for Premature Mortality: A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

What Predicts Success for a New Composite Endpoint: Graft–versus-Host Disease-Free and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation?

Clinical Relevance of HLA Supertype Matching after Myeloablative Conditioning 7/8 Unrelated Donor Hematopoietic Cell Transplantation: A CIBMTR Study

Risk Factors for Acute and Chronic Gvhd after Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Relative Risks with Umbilical Cord Blood (UCB) and Matched Related Donors (MRD)

A Refined Clinical Risk Score at Onset of Treatment for Acute Gvhd That Predicts Response to Initial Therapy, Survival and Transplant-Related Mortality

Transplantation Related Toxicity and Mortality in Older Autologous Hematopoietic Cell Transplantation Recipients

Day 21 Chimerism Is a Critical Prognostic Factor for Graft Failure and Survival in Recipients of Myeloablative Conditioning and Umbilical Cord Blood (UCB) Transplantation

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

Influence Of Organ Scores On Mortality In Chronic GVHD: Results From The Chronic GVHD Consortium

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

Long-Term Health-Related Outcomes In Survivors Of Childhood Hematopoietic Cell Transplantation (HCT): A Report From The Bone Marrow Transplant Survivor Study (BMTSS)

Do Older Patients With Moderate-Severe Chronic Graft-Versus-Host Disease Differ From Younger Patients?

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Correlation of the NIH and Vienna Skin Scores with Provider and Patient-Reported Skin Changes in Chronic Graft-Versus-Host Disease (GVHD).

Hospitalization Rates Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report From the Childhood Cancer Survivor Study (CCSS).

Association Between Genetic Variants in the Base Excision Repair Pathway and Outcomes After Hematopoietic Cell Transplant.

High Resolution HLA Matched Unrelated Donor Versus HLA Identical Sibling Transplantation for Chronic Phase CML.

New Classification of Chronic Graft Versus Host Disease: Added Clarity from the Consensus Diagnoses.

Graft-Versus-Leukemia Effect Is Equivalent in Recipients of Matched Sibling and Matched Unrelated Donor Conventional Hematopoietic Cell Transplant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only